Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

Presentation Miami Valves 2022

TAVR: Where to Now? My Crystal Ball for the next Decade

Presenter: Eberhard Grube

February 03, 2022

Presentation CACI 2019

TAVI en Argentina De los Trabajos Randomizados a la Práctica diaria - Indicación Quirúrgica 2019

Presenter: Walter Rodríguez

November 29, 2019

Presentation TCT 2019

Machine Learning Modelling vs. STS/ACC-TVT Score to Predict Mortality After Transcatheter Aortic Valve Replacement

Presenter: Pavel Overtchouk

September 26, 2019

Featured Technological Trends - Fascinating Lecture: First-in-Human Experience With Patient-Specific Computer Simulation of TAVR in Bicuspid Aortic Valve Morphology

Presentation TCT 2019

Fascinating Lecture: First-in-Human Experience With Patient-Specific Computer Simulation of TAVR in Bicuspid Aortic Valve Morphology

Presenter: Cameron Dowling

September 25, 2019

Presentation ARCH 2019

Case Selection/Guidelines

Presenter: David A. Cox

April 10, 2019

Presentation SIF 2019

Salvaging a Disaster

Presenter: Katherine Harrington

March 27, 2019

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

Presenter: Michael J. Mack, John D. Carroll

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Presenter: Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Presenter: Michael J. Mack, John C Laschinger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Megan Coylewright

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives on the Hierarchy of Valve Centers of Excellence in the US

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Brian R Lindman

June 21, 2018

Presentation

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

October 17, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Presentation

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

June 22, 2017

Presentation

Improved Costs, Outcomes With Conscious Sedation vs General Anesthesia in TAVR Patients

April 13, 2017

Presentation SIF 2017

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

Presenter: Robert D. Riley

March 11, 2017

Presentation SIF 2017

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

Presenter: Vinod H. Thourani

March 11, 2017

Presentation

2016 TCTMD Heart Team Survey

Presenter: 190204|Yael L. Maxwell

April 13, 2016

Advertisement

TAVR: Where to Now? My Crystal Ball for the next Decade

TAVI en Argentina De los Trabajos Randomizados a la Práctica diaria - Indicación Quirúrgica 2019

Machine Learning Modelling vs. STS/ACC-TVT Score to Predict Mortality After Transcatheter Aortic Valve Replacement

Fascinating Lecture: First-in-Human Experience With Patient-Specific Computer Simulation of TAVR in Bicuspid Aortic Valve Morphology

Case Selection/Guidelines

Salvaging a Disaster

TAVR in Oncology Patients With Severe AS

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Perspectives on the Hierarchy of Valve Centers of Excellence in the US

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

Improved Costs, Outcomes With Conscious Sedation vs General Anesthesia in TAVR Patients

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

State of the Art 2017: How You Will Be Managing Aortic Stenosis in 2020?

2016 TCTMD Heart Team Survey

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content